AUNANYSEServices-Offices & Clinics of Doctors of Medicine
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 22, 2026Score 5/30
$3.66−0.24 (-6.15%)
Close on Nov 20, 2026
Auna S.A. financial ratios
See a number that looks wrong?
Valuation history is only available for companies reporting in USD, so those rows are hidden.
Metric
FY2025
FY2024
FY2023
FY2022
FY2021
Margins
Gross margin
37.9%
39.3%
37.0%
35.9%
–
Operating margin
14.3%
17.9%
14.5%
10.4%
–
EBITDA margin
19.3%
22.9%
20.5%
16.0%
–
Pre-tax margin
4.5%
4.2%
-3.2%
-1.9%
–
Net profit margin
2.2%
2.5%
-6.6%
-3.5%
–
Free cash flow margin
13.1%
13.2%
12.0%
2.5%
–
Effective tax rate
44.3%
32.5%
–
–
–
Returns on capital
Return on equity
6.3%
7.5%
-20.1%
-10.3%
–
Return on assets
1.4%
1.5%
-3.6%
-1.3%
–
Return on tangible assets
1.8%
2.0%
-5.0%
-1.8%
–
Return on invested capital
7.0%
10.3%
8.9%
4.3%
–
Return on capital employed
11.6%
14.1%
11.5%
6.8%
–
Return on total capital
11.9%
14.5%
10.7%
5.2%
–
NOPAT
348.02M
528.65M
442.67M
201.12M
–
Cash flow quality
OCF / Sales
15.1%
15.2%
15.0%
6.6%
–
OCF / Net income
6.79
6.06
-2.29
-1.90
–
FCF / OCF
87.0%
86.4%
80.0%
37.0%
–
FCF / Net income
5.91
5.24
-1.84
-0.70
–
FCF / EBITDA
68.0%
57.6%
58.6%
15.3%
–
Unlevered free cash flow
1.09B
1.08B
1.09B
307.18M
–
Levered free cash flow
576.49M
577.64M
466.17M
60.14M
–
Efficiency
Asset turnover
0.61
0.59
0.54
0.37
–
Fixed asset turnover
1.92
1.81
1.58
1.06
–
Receivables turnover
4.38
4.81
5.40
4.27
–
Days sales outstanding
83.4
75.8
67.6
85.5
–
Payables turnover
10.57
7.07
7.18
7.27
–
Days payables outstanding
34.5
51.7
50.8
50.2
–
Inventory turnover
17.64
19.40
22.38
17.95
–
Days inventory outstanding
20.7
18.8
16.3
20.3
–
Operating cycle
104.1
94.7
83.9
105.8
–
Cash conversion cycle
69.6
43.0
33.0
55.6
–
CapEx to revenue
2.0%
2.1%
3.0%
4.2%
–
CapEx to OCF
13.0%
13.6%
20.0%
63.0%
–
CapEx to depreciation
0.39
0.41
0.49
0.74
–
Liquidity
Current ratio
1.11
0.88
0.92
0.42
–
Quick ratio
1.01
0.80
0.84
0.39
–
Cash ratio
0.20
0.12
0.14
0.07
–
Working capital
177.47M
-241.41M
-140.16M
-1.65B
–
Net current asset value
-3.69B
-3.75B
-4.36B
-3.84B
–
Leverage
Total debt
3.53B
3.62B
3.76B
3.35B
–
Net debt
3.20B
3.38B
3.52B
3.14B
–
Debt / Equity
2.21
2.45
2.57
3.14
–
Debt ratio
48.4%
51.1%
48.9%
50.8%
–
Assets to equity
4.56
4.79
5.25
6.19
–
Long-term debt to assets
44.1%
41.9%
43.9%
19.8%
–
Long-term debt to equity
2.01
2.01
2.30
1.23
–
Total debt / Capitalization
68.8%
71.0%
72.0%
75.9%
–
Long-term debt / Capitalization
66.8%
66.8%
69.7%
55.1%
–
Net debt / EBITDA
3.77
3.37
4.42
8.00
–
Total debt / EBITDA
4.17
3.61
4.73
8.53
–
Cash flow to debt
18.8%
18.5%
15.5%
4.9%
–
Goodwill / Assets
24.7%
24.8%
26.9%
27.4%
–
Intangibles to total assets
24.7%
24.8%
26.9%
27.4%
–
Interest coverage
EBIT / Interest expense
0.96
1.24
0.71
0.81
–
EBITDA / Interest expense
1.30
1.58
1.02
1.26
–
(EBITDA − CapEx) / Interest expense
1.17
1.44
0.87
0.93
–
Per share
Revenue per share
59.25
59.30
88.25
55.82
–
EPS (basic)
1.32
1.64
-5.78
-1.95
–
EPS (diluted)
1.32
1.63
-5.78
-1.95
–
Book value per share
21.63
19.97
33.36
24.25
–
Tangible book value per share
-2.73
-3.75
-13.75
-16.87
–
Cash per share
4.53
3.19
5.49
4.75
–
Operating cash flow per share
8.95
9.04
13.26
3.70
–
Free cash flow per share
7.79
7.81
10.61
1.37
–
CapEx per share
1.16
1.23
2.65
2.33
–
Shareholder yield
Payout ratio
–
1.0%
-2.7%
-0.15%
–
FCF payout ratio
–
0.20%
1.5%
0.22%
–
Cost structure
Stock-based comp to revenue
0.26%
0.21%
0.09%
–
–
Per employee
Total employees
15,254
200
200
200
200
Revenue per employee
287.49K
21.93M
19.38M
12.26M
–
Gross profit per employee
109.07K
8.63M
7.18M
4.40M
–
Operating profit per employee
40.99K
3.92M
2.80M
1.27M
–
Net income per employee
6.40K
551.36K
-1.27M
-428.03K
–
Free cash flow per employee
37.79K
2.89M
2.33M
300.72K
–
Growth
Revenue 1Y growth
-0.02%
13.2%
58.1%
–
–
Revenue 3Y CAGR
21.4%
–
–
–
–
Gross profit 1Y growth
-3.6%
20.2%
63.2%
–
–
Gross profit 3Y CAGR
23.7%
–
–
–
–
EBIT 1Y growth
-20.2%
39.9%
120.1%
–
–
EBIT 3Y CAGR
34.9%
–
–
–
–
EBITDA 1Y growth
-15.5%
26.0%
102.7%
–
–
EBITDA 3Y CAGR
29.2%
–
–
–
–
Net income 1Y growth
-11.5%
143.4%
-196.6%
–
–
Diluted EPS 1Y growth
-19.0%
128.2%
-196.4%
–
–
Operating cash flow 1Y growth
-0.90%
14.8%
258.1%
–
–
Operating cash flow 3Y CAGR
59.7%
–
–
–
–
Free cash flow 1Y growth
-0.20%
23.9%
675.1%
–
–
Free cash flow 3Y CAGR
112.4%
–
–
–
–
CapEx 1Y growth
-5.3%
-21.8%
13.4%
–
–
CapEx 3Y CAGR
-5.7%
–
–
–
–
Total assets 1Y growth
3.1%
-7.9%
16.6%
–
–
Total assets 3Y CAGR
3.4%
–
–
–
–
Total equity 1Y growth
8.4%
0.81%
37.6%
–
–
Total equity 3Y CAGR
14.5%
–
–
–
–
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.